Abstract
A number of studies have suggested the existence of multiple benzodiazepine binding sites in the brain1–20. We have recently reported the physical separation of two apparent benzodiazepine binding site subtypes21, the pharmacological properties, and distribution in tissue sections of which correspond to the putative type I and type II sites20,22. Benzodiazepine and γ-aminobutyric acid (GABA) receptors have been shown to interact23, and lesions of the GABAergic striatonigral pathway, which lead to GABA supersensitivity24,25, both increase the numbers of GABA binding sites24,26 and enhance GABA-stimulated benzodiazepine binding27. We demonstrate here that degeneration of striatonigral fibres increases the density of putative type I benzodiazepine binding sites in the substantia nigra and decreases the density of the putative type II sites. This suggests that type I sites that increase after denervation are postsynaptic, whereas the type II sites reduced by the lesion may be localized to axons or terminals of the striatonigral pathways.
Similar content being viewed by others
References
Squires, R. F. et al. Pharmac. Biochem. Behav. 10, 825–830 (1979).
Lippa, A. S., Coupet, J., Greenblatt, E. N., Klepner, C. A. & Beers, B. Pharmac. Biochem. Behav. 11, 99–106 (1979).
Klepner, C. A., Lippa, A. S., Benson, D. I., Bano, M. C. & Beer, B. Pharmac. Biochem. Behav. 11, 457–462 (1979).
Nielsen, M. & Braestrup, C. Nature 286, 606–607 (1980).
Braestrup, C., Nielsen, M. & Olsen, C. E. Proc. natn. Acad. Sci. U.S.A. 77, 2288–2292 (1980).
Ehlert, F. J., Roeske, W. R. & Yamamura, H. I. Life Sci. 29, 235–248 (1981).
Braestrup, C. & Neilsen, M. J. Neurochem. 37, 333–341 (1981).
Gee, K. W., Morelli, M. & Yamamura, H. I. Biochem. biophys. Res. Commun. 105, 1532–1537 (1982).
Martin, I., Brown, C. L. & Doble, A. Life Sci. 32, 1925–1933 (1983).
Gee, K. W. & Yamamura, H. I. Life Sci. 31, 1939–1945 (1982).
Chiu, T. H., Dryden, D. M. & Rosenberg, H. C. Molec. Pharmac. 21, 57–65 (1982).
Quast, U., Mahlman, H. & Vollmer, K. O. Molec. Pharmac. 22, 20–25 (1982).
Mohler, H. & Richards, J. G. Nature 294, 763–765 (1981).
Sieghart, W. & Karobath, M. Nature 286, 285–287 (1980).
Sieghart, W., Supavilai, P. & Karobath, M. in Pharmacology of Benzodiazepines (eds Usdin, E., Skolnick, P., Tallman, J. F., Greenblatt, D. & Paul, S. M.) 141–148 (Macmillan, London, 1983).
Thomas, J. W. & Tallman, J. F. J. biol. Chem. 256, 9838–9842 (1981).
Mohler, H., Battersby, M. K. & Richards, J. G. Proc. natn. Acad. Sci. U.S.A. 77, 1660–1670 (1980).
Gavish, M. & Snyder, S. H. Nature 287, 651–652 (1980).
Squires, R. F. & Saederup, E. Molec. Pharmac. 22, 327–334 (1982).
Young, W. S. III, Niehoff, D., Kuhar, M. J., Beer, B. & Lippa, A. S. J. Pharmac. exp. Ther. 216, 425–430 (1981).
Lo, M. M. S., Strittmatter, S. M. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 79, 680–684 (1982).
Lo, M. M. S., Niehoff, D. L., Kuhar, M. J. & Snyder, S. H. Neurosci. Lett. 39, 37–44 (1983).
Tallman, J. F., Paul, S. M., Skolnick, P. & Gallager, D. W. Science 207, 274–281 (1980).
Waddington, J. L. & Cross, A. J. Nature 276, 618–620 (1978).
Kuriyama, K. & Kurihara, E. in Problems in GABA Research from Brain to Bacteria (eds Okada, Y. & Roberts, E.) 207–215 (Excerpta Medica, Amsterdam, 1982).
Guidotti, A., Gale, K., Suria, A. & Toffano, G. Brain Res. 172, 566–571 (1979).
Shibuya, H., Gale, K. & Pert, C. B. Eur. J. Pharmac. 62, 243–244 (1980).
Niehoff, D. L. et al. J. Pharmac. exp. Ther. 221, 670–675 (1982).
Lippa, A. S., Beer, B., Sano, M. C., Vogel, R. A. & Meyerson, L. R. Life Sci. 28, 2343–2347 (1981).
Niehoff, D. L. & Kuhar, M. J. Neurosci. Abstr. 8, 645 (1982).
Ehlert, F. J., Roeske, W. R. & Yamamura, H. I. Life Sci. 29, 235–248 (1982).
Williams, E. F., Paul, S. M., Rice, K. C., Cain, M. & Skolnick, P. FEES Lett. 132, 269–272 (1982).
Kohler, C. & Schwarcz, R. Neuroscience 8, 819–835 (1983).
Hunkeler, W. et al. Nature 290, 514–516 (1982).
Martin, I. L. & Candy, J. M. Neuropharmacology 17, 993–998 (1978).
Costa, T., Rodbard, D. & Pert, C. B. Nature 277, 315–317 (1979).
Lo, M. M. S., Trifiletti, R. R. & Snyder, S. H. in Pharmacology of Benzodiazepines (eds Usdin, E., Skolnick, P., Tallman, J. F., Greenblatt, D. & Paul, S. M.) 165–173 (Macmillan, London, 1983).
Biggio, G., Corda, M. G., Lamberti, C. & Lessa, G. L. Eur. J. Pharmac. 58, 215–216 (1979).
Unnerstall, J. R., Niehoff, D. L., Kuhar, M. J. & Palacios, J. M. J. Neurosci. Meth. 6, 59–73 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lo, M., Niehoff, D., Kuhar, M. et al. Differential localization of type I and type II benzodiazepine binding sites in substantia nigra. Nature 306, 57–60 (1983). https://doi.org/10.1038/306057a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/306057a0
- Springer Nature Limited
This article is cited by
-
Decreased benzodiazepine receptor binding in epileptic El mice: A quantitative autoradiographic study
Neurochemical Research (1990)
-
Sleep and benzodiazepine receptor sub-types
Journal of Neural Transmission (1987)
-
Benzodiazepine receptors resolved
Experientia (1986)
-
Benzodiazepine receptors: Multiple receptors or multiple conformations?
Journal of Neural Transmission (1985)
-
Localization and heterogeneity of central benzodiazepine receptors
Neurochemical Research (1985)